These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28978251)

  • 1. Intermolecular interactions between DNA and methamphetamine, amphetamine, ecstasy and their major metabolites.
    Reis AFVF; Gonçalves ILP; Neto AFG; Santos AS; Kuca K; Nepovimova E; Neto AMJC
    J Biomol Struct Dyn; 2018 Sep; 36(12):3047-3057. PubMed ID: 28978251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone.
    Dal Cason TA
    Forensic Sci Int; 2001 Jun; 119(2):168-94. PubMed ID: 11376983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.
    Todd G; Burns L; Pearson-Dennett V; Esterman A; Faulkner PL; Wilcox RA; Thewlis D; Vogel AP; White JM
    Drug Alcohol Depend; 2019 Dec; 205():107595. PubMed ID: 31600615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.
    Moratalla R; Khairnar A; Simola N; Granado N; García-Montes JR; Porceddu PF; Tizabi Y; Costa G; Morelli M
    Prog Neurobiol; 2017 Aug; 155():149-170. PubMed ID: 26455459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
    Brière FN; Fallu JS; Janosz M; Pagani LS
    J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex assay of amphetamine, methamphetamine, and ecstasy drug using CEDIA technology.
    Loor R; Lingenfelter C; Wason PP; Tang K; Davoudzadeh D
    J Anal Toxicol; 2002; 26(5):267-73. PubMed ID: 12166813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
    Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
    Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?
    Byard RW; Gilbert J; James R; Lokan RJ
    Am J Forensic Med Pathol; 1998 Sep; 19(3):261-5. PubMed ID: 9760094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine.
    Reese EA; Norimatsu Y; Grandy MS; Suchland KL; Bunzow JR; Grandy DK
    J Med Chem; 2014 Jan; 57(2):378-90. PubMed ID: 24354319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychostimulant use and the brain.
    Lappin JM; Sara GE
    Addiction; 2019 Nov; 114(11):2065-2077. PubMed ID: 31321819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrochemical oxidation of amphetamine-like drugs and application to electroanalysis of ecstasy in human serum.
    Garrido EM; Garrido JM; Milhazes N; Borges F; Oliveira-Brett AM
    Bioelectrochemistry; 2010 Aug; 79(1):77-83. PubMed ID: 20051327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives.
    Timár J; Gyarmati S; Szabó A; Fürst S
    Behav Pharmacol; 2003 May; 14(3):199-206. PubMed ID: 12799521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4-methylendioxy-N-methylamphetamine (MDMA) in seized street drug samples from southern Germany.
    Losacker M; Zörntlein S; Schwarze B; Staudt S; Röhrich J; Hess C
    Drug Test Anal; 2022 Mar; 14(3):557-566. PubMed ID: 34169674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into scFv:drug binding using the molecular dynamics simulation and free energy calculation.
    Hu G; Zhang Q; Chen LY
    J Mol Model; 2011 Aug; 17(8):1919-26. PubMed ID: 21110054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.
    Peters FT; Samyn N; Wahl M; Kraemer T; De Boeck G; Maurer HH
    J Anal Toxicol; 2003; 27(8):552-9. PubMed ID: 14670133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
    Schwaninger AE; Meyer MR; Maurer HH
    Drug Metab Dispos; 2011 Nov; 39(11):1998-2002. PubMed ID: 21795466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.